0001610618-21-000071.txt : 20210827 0001610618-21-000071.hdr.sgml : 20210827 20210827184108 ACCESSION NUMBER: 0001610618-21-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210825 FILED AS OF DATE: 20210827 DATE AS OF CHANGE: 20210827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ward Shane CENTRAL INDEX KEY: 0001638380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 211220457 MAIL ADDRESS: STREET 1: C/O VERSARTIS, INC. STREET 2: 4200 BOHANNON DR., SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 wf-form4_163010405399223.xml FORM 4 X0306 4 2021-08-25 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001638380 Ward Shane 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 0 1 0 0 CHIEF LEGAL OFFICER Stock Option (right to buy) 2.16 2021-08-25 4 A 0 250000 0 A 2031-08-24 Common Stock 250000.0 250000 D 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of August 25, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on August 25, 2025. /s/ Shane Ward 2021-08-27